BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 7069775)

  • 21. Circulating immune complexes and complement levels in hemophilic children.
    Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P
    J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characterization of immune complexes in normal pregnancies].
    Saito S
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):391-400. PubMed ID: 3872337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement levels of C4, C3C, factor B, and C1 inactivator in peripheral and retroplacental blood of parturient women with EPH gestosis.
    Zdanowicz A; Jabłońska E; Pietruska Z; Bielecki M
    Ann Med Univ Bialyst Pol; 1993; 38(1):60-7. PubMed ID: 7922487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Forearm blood flow in pre-eclampsia.
    Bowyer L; Brown MA; Jones M
    BJOG; 2003 Apr; 110(4):383-91. PubMed ID: 12699800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further evidence against preeclampsia as an immune complex disease.
    Balasch J; Mirapeix E; Borche L; Vives J; González-Merlo J
    Obstet Gynecol; 1981 Oct; 58(4):435-7. PubMed ID: 6456434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
    Spencer K; Cowans NJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leptin levels in pregnancy: marker for fat accumulation and mobilization?
    Sattar N; Greer IA; Pirwani I; Gibson J; Wallace AM
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):278-83. PubMed ID: 9539272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of alpha-human atrial natriuretic peptide in normal pregnancy and in pre-eclampsia.
    Rizk DE
    J Obstet Gynaecol; 1997 May; 17(3):234-8. PubMed ID: 15511835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-2 receptor serum concentrations in normal pregnancy and pre-eclampsia.
    Romero-Adrián T; Ruiz A; Molina-Vílchez R; Estévez J; Atencio R
    Invest Clin; 2002 Jun; 43(2):73-8. PubMed ID: 12108028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia.
    Spencer K; Cowans NJ; Nicolaides KH
    Prenat Diagn; 2008 Jan; 28(1):7-10. PubMed ID: 18000943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelin system in normal and hypertensive pregnancy.
    Slowinski T; Neumayer HH; Stolze T; Gossing G; Halle H; Hocher B
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():446S-449S. PubMed ID: 12193142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GRP78 as a marker of pre-eclampsia: an exploratory study.
    Laverrière A; Landau R; Charvet I; Irion O; Bischof P; Morales M; Cohen M
    Mol Hum Reprod; 2009 Sep; 15(9):569-74. PubMed ID: 19482905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periodontal disease as a risk factor for pre-eclampsia: a case control study.
    Canakci V; Canakci CF; Canakci H; Canakci E; Cicek Y; Ingec M; Ozgoz M; Demir T; Dilsiz A; Yagiz H
    Aust N Z J Obstet Gynaecol; 2004 Dec; 44(6):568-73. PubMed ID: 15598299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia.
    Chaiworapongsa T; Romero R; Kim YM; Kim GJ; Kim MR; Espinoza J; Bujold E; Gonçalves L; Gomez R; Edwin S; Mazor M
    J Matern Fetal Neonatal Med; 2005 Jan; 17(1):3-18. PubMed ID: 15804781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis factor-alpha in the placenta is not elevated in pre-eclamptic patients despite its elevation in peripheral blood.
    Hayashi M; Ueda Y; Yamaguchi T; Sohma R; Shibazaki M; Ohkura T; Inaba N
    Am J Reprod Immunol; 2005 Mar; 53(3):113-9. PubMed ID: 15727564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal study of platelet size changes in gestation and predictive power of elevated MPV in development of pre-eclampsia.
    Dundar O; Yoruk P; Tutuncu L; Erikci AA; Muhcu M; Ergur AR; Atay V; Mungen E
    Prenat Diagn; 2008 Nov; 28(11):1052-6. PubMed ID: 18973157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of serum leptin level as a marker of severity of pre eclampsia.
    Mumtaz F; Memon AR; Yousfani S; Tahir SM; Khushk I; Memon M; Memon A
    J Ayub Med Coll Abbottabad; 2008; 20(1):13-5. PubMed ID: 19024177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An assay for antigen-antibody complexes in human sera using C1q-enzyme conjugates.
    Stimson WH; McAdam A; Hutchison RS
    J Clin Lab Immunol; 1981 Mar; 5(2):129-31. PubMed ID: 7012357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of labour and placental separation on the shedding of syncytiotrophoblast microparticles, cell-free DNA and mRNA in normal pregnancy and pre-eclampsia.
    Reddy A; Zhong XY; Rusterholz C; Hahn S; Holzgreve W; Redman CW; Sargent IL
    Placenta; 2008 Nov; 29(11):942-9. PubMed ID: 18834630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on relationship between complement and blood coagulation system in toxemia of pregnancy (author's transl)].
    Takahashi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Mar; 34(3):341-50. PubMed ID: 7069248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.